Literature DB >> 19541744

Structural and functional characterization of the interdomain interaction in the mineralocorticoid receptor.

Jyotsna B Pippal1, Yizhou Yao, Fraser M Rogerson, Peter J Fuller.   

Abstract

The mineralocorticoid receptor (MR) plays a central role in electrolyte homeostasis and in cardiovascular disease. We have previously reported a ligand-dependent N/C-interaction in the MR. In the present study we sought to fully characterize the MR N/C-interaction. By using a range of natural and synthetic MR ligands in a mammalian two-hybrid assay we demonstrate that in contrast to aldosterone, which strongly induces the interaction, the physiological ligands deoxycorticosterone and cortisol weakly promote the interaction but predominantly inhibit the aldosterone-mediated N/C-interaction. Similarly, progesterone and dexamethasone antagonize the interaction. In contrast, the synthetic agonist 9alpha-fludrocortisol robustly induces the interaction. The ability of the N/C interaction to discriminate between MR agonists suggests a subtle conformational difference in the ligand-binding domain induced by these agonists. We also demonstrate that the N/C interaction is not cell specific, consistent with the evidence from a glutathione-S-transferase pull-down assay, of a direct protein-protein interaction between the N- and C-terminal domains of the MR. Examination of a panel of deletions in the N terminus suggests that several regions may be critical to the N/C-interaction. These studies have identified functional differences between physiological MR ligands, which suggest that the ligand-specific dependence of the N/C-interaction may contribute to the differential activation of the MR that has been reported in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541744      PMCID: PMC2737563          DOI: 10.1210/me.2009-0032

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  41 in total

Review 1.  11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.

Authors:  P C White; T Mune; A K Agarwal
Journal:  Endocr Rev       Date:  1997-02       Impact factor: 19.871

2.  The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions.

Authors:  Laurent Pascual-Le Tallec; Federico Simone; Say Viengchareun; Geri Meduri; Michael J Thirman; Marc Lombès
Journal:  Mol Endocrinol       Date:  2005-01-13

3.  Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity.

Authors:  E Langley; J A Kemppainen; E M Wilson
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

4.  The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.

Authors:  Eva Estébanez-Perpiñá; Jamie M R Moore; Ellena Mar; Edson Delgado-Rodrigues; Phuong Nguyen; John D Baxter; Benjamin M Buehrer; Paul Webb; Robert J Fletterick; R Kiplin Guy
Journal:  J Biol Chem       Date:  2004-11-24       Impact factor: 5.157

5.  Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.

Authors:  Bin He; Robert T Gampe; Adam J Kole; Andrew T Hnat; Thomas B Stanley; Gang An; Eugene L Stewart; Rebecca I Kalman; John T Minges; Elizabeth M Wilson
Journal:  Mol Cell       Date:  2004-11-05       Impact factor: 17.970

6.  Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo.

Authors:  M J Tetel; P H Giangrande; S A Leonhardt; D P McDonnell; D P Edwards
Journal:  Mol Endocrinol       Date:  1999-06

7.  11-deoxycorticosterone is a potent agonist of the rainbow trout (Oncorhynchus mykiss) mineralocorticoid receptor.

Authors:  A Sturm; N Bury; L Dengreville; J Fagart; G Flouriot; M E Rafestin-Oblin; P Prunet
Journal:  Endocrinology       Date:  2004-10-14       Impact factor: 4.736

8.  Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer.

Authors:  E Langley; Z X Zhou; E M Wilson
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

Review 9.  Mineralocorticoid receptors: emerging complexity and functional diversity.

Authors:  Alex Odermatt; Atanas G Atanasov
Journal:  Steroids       Date:  2008-10-30       Impact factor: 2.668

10.  Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.

Authors:  Charmian A Quigley; Jiann-an Tan; Bin He; Zhong-xun Zhou; Farida Mebarki; Yves Morel; Maguelone G Forest; Pierre Chatelain; E Martin Ritzén; Frank S French; Elizabeth M Wilson
Journal:  Mech Ageing Dev       Date:  2004 Oct-Nov       Impact factor: 5.432

View more
  14 in total

Review 1.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: circadian rhythm-associated alterations of glucocorticoid actions in target tissues.

Authors:  Tomoshige Kino; George P Chrousos
Journal:  Mol Cell Endocrinol       Date:  2010-12-10       Impact factor: 4.102

Review 3.  Structural features discriminate androgen receptor N/C terminal and coactivator interactions.

Authors:  Emily B Askew; John T Minges; Andrew T Hnat; Elizabeth M Wilson
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

4.  Analysis of interdomain interactions of the androgen receptor.

Authors:  Elizabeth M Wilson
Journal:  Methods Mol Biol       Date:  2011

5.  Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display.

Authors:  Jun Yang; Ching-yi Chang; Rachid Safi; James Morgan; Donald P McDonnell; Peter J Fuller; Colin D Clyne; Morag J Young
Journal:  Mol Endocrinol       Date:  2010-11-24

6.  Molecular evolution of the switch for progesterone and spironolactone from mineralocorticoid receptor agonist to antagonist.

Authors:  Peter J Fuller; Yi-Zhou Yao; Ruitao Jin; Sitong He; Beatriz Martín-Fernández; Morag J Young; Brian J Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-22       Impact factor: 11.205

7.  NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor.

Authors:  Ayano Murai-Takeda; Hirotaka Shibata; Isao Kurihara; Sakiko Kobayashi; Kenichi Yokota; Noriko Suda; Yuko Mitsuishi; Rie Jo; Hirochika Kitagawa; Shigeaki Kato; Takao Saruta; Hiroshi Itoh
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

8.  Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function.

Authors:  Katelee Barrett Mueller; Qing Lu; Najwa N Mohammad; Victor Luu; Amy McCurley; Gordon H Williams; Gail K Adler; Richard H Karas; Iris Z Jaffe
Journal:  Endocrinology       Date:  2014-07-22       Impact factor: 4.736

9.  Sensitivity and Isoform Specificity of 18F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer.

Authors:  Kelley Salem; Manoj Kumar; Yongjun Yan; Justin J Jeffery; Kyle C Kloepping; Ciara J Michel; Ginny L Powers; Aparna M Mahajan; Amy M Fowler
Journal:  J Nucl Med       Date:  2018-07-20       Impact factor: 10.057

Review 10.  Structural determinants of activation of the mineralocorticoid receptor: an evolutionary perspective.

Authors:  Peter J Fuller; Yi-Zhou Yao; Jun Yang; Morag J Young
Journal:  J Hum Hypertens       Date:  2020-05-28       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.